CLX Insider Trading
CLOROX CO /DE/ | Specialty Cleaning, Polishing and Sanitation Preparations
Comprehensive Trading Performance Summary
The investment history of corporate insiders at CLOROX CO /DE/ provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Specialty Cleaning, Polishing and Sanitation Preparations sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2011-02-16 04:20 | 2011-02-11 | HEINRICH DANIEL J | Officer - EVP-Chief Financial Officer | OPT+S | $70.57 | 35,537 | $2,507,750 | 4,535 | 0.0% |
| 2011-02-16 04:19 | 2011-02-11 | TATASEO FRANK A | Officer - EVP - Strategy & Growth | SELL | $71.09 | 21,200 | $1,507,087 | 928 | -95.8% |
| 2011-02-15 03:28 | 2011-02-10 | MATSCHULLAT ROBERT W | Director | OPT+S | $66.23 | 2,000 | $132,458 | 1,324 | 0.0% |
| 2011-02-12 00:02 | 2011-02-09 | BOGGAN DANIEL JR | Director | OPT+S | $66.25 | 2,000 | $132,494 | 1,241 | 0.0% |
| 2011-02-09 01:04 | 2011-02-04 | SPRINGER MARY BETH | Officer - EVP-Int'l/Natural Pers Care | SELL | $65.02 | 18,600 | $1,209,333 | 4,379 | -80.9% |
| 2010-11-12 23:57 | 2010-11-10 | MICHAEL GARY G | Director | OPT+S | $62.66 | 6,000 | $375,960 | 6,651 | 0.0% |
| 2010-11-04 03:23 | 2010-11-01 | DELKER WAYNE L | Officer - SVP-Chief Innovation Officer | OPT+S | $66.59 | 22,378 | $1,490,050 | 19,496 | 0.0% |
| 2010-10-13 01:02 | 2010-10-08 | TATASEO FRANK A | Officer - EVP - Strategy & Growth | OPT+S | $68.16 | 46,504 | $3,169,517 | 22,128 | 0.0% |
| 2010-09-09 01:45 | 2010-09-03 | Britanik Thomas P | Officer - SVP-Chief Marketing Officer | OPT+S | $66.00 | 5,517 | $364,122 | 18,473 | 0.0% |
| 2010-09-09 01:23 | 2010-09-03 | Foster James E | Officer - SVP Chief Product Supply Off. | SELL | $65.93 | 365 | $24,063 | 8,378 | -4.2% |
| 2010-09-09 01:23 | 2010-09-03 | KANE JACQUELINE P | Officer - SR VP- HR & Corporate Affairs | SELL | $65.86 | 3,468 | $228,393 | 571 | -85.9% |
| 2010-09-02 02:59 | 2010-08-30 | TATASEO FRANK A | Officer - EVP - Strategy & Growth | OPT+S | $64.60 | 37,534 | $2,424,520 | 23,632 | 0.0% |
| 2010-08-26 01:22 | 2010-08-23 | ROETH GEORGE C | Officer - SVP-General Manager | SELL | $64.38 | 5,000 | $321,900 | 18,519 | -21.3% |
| 2010-08-20 23:31 | 2010-08-19 | HEINRICH DANIEL J | Officer - EVP-Chief Financial Officer | SELL | $64.72 | 173 | $11,225 | 0 | -100.0% |
| 2010-08-10 04:07 | 2010-08-05 | LaMontagne Grant J | Officer - SVP-Chief Customer Officer | OPT+S | $64.50 | 12,032 | $776,064 | 6,347 | 0.0% |
| 2010-07-16 02:03 | 2010-07-13 | DELKER WAYNE L | Officer - SVP-Chief Innovation Officer | OPT+S | $65.00 | 6,721 | $436,884 | 19,596 | 0.0% |
| 2010-07-16 02:03 | 2010-07-13 | HEINRICH DANIEL J | Officer - EVP-Chief Financial Officer | OPT+S | $65.02 | 43,993 | $2,860,460 | 0 | 0.0% |
| 2010-06-29 23:13 | 2010-06-25 | KANE JACQUELINE P | Officer - SR VP- HR & Corporate Affairs | SELL | $63.44 | 10,039 | $636,874 | 24,471 | -29.1% |
| 2010-05-24 23:10 | 2010-05-20 | FRIEDMAN TULLY M | Director | OPT+S | $63.55 | 2,000 | $127,100 | 20,105 | 0.0% |
| 2010-05-10 23:13 | 2010-05-05 | BOGGAN DANIEL JR | Director | OPT+S | $63.04 | 2,000 | $126,079 | 1,241 | 0.0% |
| 2010-04-28 23:41 | 2010-04-26 | SPRINGER MARY BETH | Officer - EVP-Int'l/Natural Pers Care | OPT+S | $65.04 | 15,077 | $980,646 | 22,336 | 0.0% |
| 2010-04-23 23:13 | 2010-04-21 | DELKER WAYNE L | Officer - SVP-Chief Innovation Officer | OPT+S | $65.02 | 6,721 | $436,995 | 19,150 | 0.0% |
| 2010-04-22 23:03 | 2010-04-20 | SPRINGER MARY BETH | Officer - EVP-Int'l/Natural Pers Care | OPT+S | $64.85 | 6,568 | $425,961 | 22,336 | 0.0% |
| 2010-04-08 03:53 | 2010-04-05 | JOHNSON THOMAS D | Officer - VP GBSS & Chief Acct. Officer | OPT+S | $64.02 | 6,036 | $386,398 | 10,951 | 0.0% |
| 2010-03-25 23:40 | 2010-03-23 | Britanik Thomas P | Officer - SVP-Chief Marketing Officer | OPT+S | $65.00 | 6,286 | $408,590 | 14,620 | 0.0% |
| 2010-03-25 23:40 | 2010-03-23 | Foster James E | Officer - SVP Chief Product Supply Off. | OPT+S | $65.00 | 4,263 | $277,095 | 7,281 | 0.0% |
| 2010-03-25 23:40 | 2010-03-23 | DELKER WAYNE L | Officer - SVP-Chief Innovation Officer | OPT+S | $65.00 | 6,720 | $436,800 | 18,704 | 0.0% |
| 2010-03-25 23:41 | 2010-03-23 | HEINRICH DANIEL J | Officer - EVP-Chief Financial Officer | OPT+S | $65.05 | 37,474 | $2,437,508 | 36,734 | 0.0% |
| 2010-03-18 23:33 | 2010-03-16 | TATASEO FRANK A | Officer - EVP - Strategy & Growth | SELL | $64.02 | 5,709 | $365,467 | 16,592 | -25.6% |
| 2010-02-24 00:20 | 2010-02-19 | LaMontagne Grant J | Officer - SVP-Chief Customer Officer | OPT+S | $60.83 | 16,988 | $1,033,412 | 5,844 | 0.0% |
| 2010-02-13 00:32 | 2010-02-10 | MATSCHULLAT ROBERT W | Director | OPT+S | $60.46 | 2,000 | $120,920 | 1,324 | 0.0% |
| 2009-12-16 01:53 | 2009-12-11 | PEIROS LARRY | Officer - Executive VP-COO North America | OPT+S | $63.01 | 34,708 | $2,187,007 | 36,362 | 0.0% |
| 2009-12-12 00:11 | 2009-12-09 | HEINRICH DANIEL J | Officer - EVP-Chief Financial Officer | OPT+S | $62.00 | 23,530 | $1,458,900 | 38,192 | 0.0% |
| 2009-12-12 00:11 | 2009-12-09 | BOGGAN DANIEL JR | Director | OPT+S | $61.20 | 1,000 | $61,200 | 1,241 | 0.0% |
| 2009-12-11 01:05 | 2009-12-08 | JOHNSON THOMAS D | Officer - VP GBSS & Chief Acct. Officer | SELL | $60.54 | 2,600 | $157,409 | 10,558 | -19.8% |
| 2009-12-10 01:22 | 2009-12-07 | DELKER WAYNE L | Officer - SVP-Chief Innovation Officer | OPT+S | $60.94 | 6,441 | $392,482 | 18,258 | 0.0% |
| 2009-12-03 00:50 | 2009-11-30 | HEINRICH DANIEL J | Officer - EVP-Chief Financial Officer | SELL | $59.90 | 808 | $48,403 | 36,720 | -2.2% |
| 2009-11-19 02:13 | 2009-11-16 | SPRINGER MARY BETH | Officer - EVP-Int'l/Natural Pers Care | OPT+S | $59.97 | 696 | $41,739 | 22,336 | 0.0% |
| 2009-11-12 16:57 | 2009-11-09 | Britanik Thomas P | Officer - SVP-Chief Marketing Officer | OPT+S | $60.91 | 4,691 | $285,729 | 13,166 | 0.0% |
| 2009-11-13 00:38 | 2009-11-10 | ROETH GEORGE C | Officer - SVP-General Manager | OPT+S | $61.00 | 41,351 | $2,522,208 | 19,550 | 0.0% |
| 2009-09-26 00:56 | 2009-09-23 | SPRINGER MARY BETH | Officer - EVP-Int'l/Natural Pers Care | OPT+S | $59.20 | 4,273 | $252,952 | 22,336 | 0.0% |
| 2009-08-10 23:16 | 2009-08-06 | HEINRICH DANIEL J | Officer - EVP-Chief Financial Officer | SELL | $57.88 | 4,000 | $231,520 | 0 | -100.0% |
| 2009-07-31 01:07 | 2009-07-28 | DELKER WAYNE L | Officer - SVP-Chief Innovation Officer | OPT+S | $60.00 | 12,003 | $720,196 | 13,652 | 0.0% |
| 2009-07-31 01:06 | 2009-07-28 | TATASEO FRANK A | Officer - Executive VP - Functional Op | OPT+S | $60.00 | 1,345 | $80,700 | 15,367 | 0.0% |
| 2009-07-31 01:07 | 2009-07-28 | PEIROS LARRY | Officer - Executive VP-COO North America | OPT+S | $60.06 | 52,503 | $3,153,393 | 21,504 | 0.0% |
| 2009-06-18 01:01 | 2009-06-15 | HEINRICH DANIEL J | Officer - Sr. VP-Chief Financial Officer | SELL | $56.05 | 10,424 | $584,260 | 4,000 | -72.3% |
| 2009-06-17 03:35 | 2009-06-15 | BOGGAN DANIEL JR | Director | OPT+S | $55.74 | 1,000 | $55,738 | 1,241 | 0.0% |
| 2009-04-22 00:16 | 2009-04-20 | TATASEO FRANK A | Officer - Executive VP - Functional Op | OPT+S | $55.74 | 10,162 | $566,436 | 15,312 | 0.0% |
| 2009-03-11 23:19 | 2009-03-09 | BOGGAN DANIEL JR | Director | SELL | $45.86 | 444 | $20,362 | 1,136 | -28.1% |
| 2008-11-08 04:07 | 2008-11-05 | PEIROS LARRY | Officer - Executive VP-COO North America | OPT+S | $61.94 | 23,375 | $1,447,848 | 24,216 | 0.0% |
How to Interpret $CLX Trades
Not every insider transaction in CLOROX CO /DE/ is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $CLX shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for CLX
Insider activity data for CLOROX CO /DE/ is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $CLX, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.